U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152288) titled 'Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment' on Aug. 26.
Brief Summary: The study is being conducted to compare the pharmacokinetics, safety, and pharmacodynamics of HSK39297 in subjects with mild to moderate hepatic impairment and normal hepatic function
Study Start Date: May 29
Study Type: INTERVENTIONAL
Condition:
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Intervention:
DRUG: HSK39297 tablets
oral
DRUG: HSK39297 tablets
oral
DRUG: HSK39297 tablets
oral
Recruitment Status: RECRUITING
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Published by HT Digital...